# Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy

> **NCT00067561** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 702 (actual)

## Conditions studied

- Irritable Colon
- Irritable Bowel Syndrome (IBS)

## Interventions

- **DRUG:** Alosetron

## Key facts

- **NCT ID:** NCT00067561
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2005-01
- **Final completion:** 2005-01
- **Target enrollment:** 702 (ACTUAL)
- **Last updated:** 2015-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00067561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00067561, "Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00067561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*